These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 8168767

  • 21. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA.
    J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Latent autoimmune diabetes in adults (LADA): a case series.
    Tan HH, Lim SC.
    Singapore Med J; 2001 Nov; 42(11):513-6. PubMed ID: 11876376
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Controversies on humoral immune markers of insulin-dependent diabetes mellitus.
    Falorni A, Kassi G, Murdolo G, Calcinaro F.
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():307-17. PubMed ID: 9642661
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
    Schilling I, Conrad K, Füssel M, Henker J.
    Dtsch Med Wochenschr; 2003 Jan 31; 128(5):185-9. PubMed ID: 12557109
    [Abstract] [Full Text] [Related]

  • 30. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
    Desailloud R, Fajardy I, Vambergue A, Prevost G, Pigny P, Fontaine P.
    Diabetes Metab; 2000 Nov 31; 26(5):353-60. PubMed ID: 11119014
    [Abstract] [Full Text] [Related]

  • 31. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C, Lazzarotto F, Fusari A, Zanchetta R, Benedini S, Pedini B, Moscon A, Presotto F.
    Acta Diabetol; 2006 Nov 31; 43(3):79-83. PubMed ID: 17143785
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG, Mazza CS, Valdez SN, Stumpo RR, Papouchado ML, Iacono RF, Cardoso Landaburu AC, Sica MP, Ozuna B, Poskus E.
    Medicina (B Aires); 2001 Nov 31; 61(3):279-83. PubMed ID: 11474874
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Differential diagnosis of diabetes mellitus in adults: assessment of immunogenetic markers of insulin dependence].
    Turiev GS, Ametov AS, Kondrat'ev IaIu, Timofeev AV.
    Klin Med (Mosk); 2004 Nov 31; 82(1):47-52. PubMed ID: 15022597
    [Abstract] [Full Text] [Related]

  • 37. The use of immunological markers in IDDM after more than 20 years from ICA description.
    Dotta F, Dionisi S, Farilla L, Di Mario U.
    Diabetes Metab Rev; 1996 Jul 31; 12(2):121-6. PubMed ID: 8877281
    [No Abstract] [Full Text] [Related]

  • 38. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G, Bazzigaluppi E, Mangili R, Bosi E, Bonifacio E.
    Diabetologia; 1997 Apr 31; 40(4):485. PubMed ID: 9112029
    [No Abstract] [Full Text] [Related]

  • 39. [Early detection of type I diabetes].
    Kolb H.
    Dtsch Med Wochenschr; 1990 Nov 16; 115(46):1774. PubMed ID: 2226191
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.